Ligand to Report First Quarter 2026 Financial Results on May 7, 2026

Go back to Ligand to Report First Quarter 2026 Financial Results on May 7, 2026
LIGAND PHARMA (NASDAQ: LGND) Delayed: 320.42 --0 (-0%)
Previous Close $320.42    52 Week High $139.79 
Open $320.42    52 Week Low $82.07 
Day High $320.42    P/E 745.16 
Day Low $320.42    EPS $0.43 
Volume